NovoCure Ltd — Director's Dealing 2023

Mar 3, 2023

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2023-02-22

Reporting Person: Ocean Allyson J (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to buy)	$76.97	2033-02-27	Ordinary Shares (13989.00)		Direct

Footnotes

F1: These stock options will vest in equal parts on the first, second and third anniversary of the grant date.